Text search

search Exact search

Found 668 results for log2(Irr24h/Irr12h) between 0 and 1 and fdr <= 0.05. Showing entries 1-20.

Graph Cluster Transcripts Mean logCPM Classification Smed/Human type Human gene Annotation
1. MligTC454_44601 Mlig032079.g5 9.61 Sexual_biased Mlig032079.g5 {REF} {Length: 2918} {Smed: dd_Smed_v6_23342_0_1, dd_Smed_v6_23342_0_1, [RH, Score=57.4, Expect=5e-12]} {RNA1509_313, RNA1509_32450, RNA1509_33478, RNA1509_340} {SMEDTYPE: Sexual_biased [CUFF.83600.0]}
2. MligTC454_51708 Mlig007552.g3 8.61 Mlig007552.g3 {REF} {Length: 3797} {RNA1509_246, RNA1509_50041}
3. MligTC454_72810 Mlig010039.g6 8.55 Neoblast; X1; Sexual_biased YWHAZ Mlig010039.g6 {REF} {Length: 2827} {Pfam: 14-3-3 protein [PF00244.20, score=344.3]} {Human: ENSG00000164924, YWHAZ, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta, [RH, Score=344, Expect=2e-120]; ENSG00000166913, YWHAB, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta, [RH, Score=342, Expect=1e-119]} {Mouse: ENSMUSG00000022285, Ywhaz, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide, [RH, Score=348, Expect=3e-122]} {Dmel: FBgn0004907, 14-3-3zeta, [RH, Score=348, Expect=3e-122]} {Celegans: WBGene00001502, ftt-2, 14-3-3-like protein 2, [RH, Score=346, Expect=2e-121]} {Smed: dd_Smed_v6_5419_0_1, dd_Smed_v6_5419_0_1, [RH, Score=350, Expect=4e-123]} {RNA1509_1212, RNA1509_153, RNA1509_15867, RNA1509_17661, RNA1509_29156, RNA1509_48209} {SMEDTYPE: Neoblast [dd_Smed_v6_5419_0_1, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide (YWHAB)]} {SMEDTYPE: X1 [raj_facs_types]} {SMEDTYPE: Sexual_biased [CUFF.219670.0]}
4. MligTC454_63419 Mlig029804.g1 8.31 Gut; Xins; Sexual_biased AC099489.1 Mlig029804.g1 {REF} {Length: 10909} {Pfam: Lipoprotein amino terminal region [PF01347.22, score=126.2]; Domain of unknown function (DUF1943) [PF09172.11, score=98.4]; von Willebrand factor type D domain [PF00094.25, score=30.9]} {Human: ENSG00000188897, AC099489.1, vitellogenin, [Score=65.5, Expect=2e-09]} {Mouse: ENSMUSG00000020609, Apob, apolipoprotein B, [Score=57.8, Expect=3e-07]} {Dmel: FBgn0087002, apolpp, apolipophorin, [Score=77.0, Expect=4e-13]} {Smed: dd_Smed_v6_636_0_1, dd_Smed_v6_636_0_1, [Score=145, Expect=4e-34]} {RNA1509_19, RNA1509_35407} {SMEDTYPE: Gut [dd_Smed_v6_636_0_1, apolipoprotein B (APOB)]} {SMEDTYPE: Xins [raj_facs_types]} {SMEDTYPE: Sexual_biased [CUFF.234108.0]}
5. MligTC454_60239 Mlig004381.g1 8.19 Mlig004381.g1 {REF} {Length: 2709} {Pfam: Ependymin [PF00811.18, score=60.8]} {RNA1509_14852, RNA1509_19075, RNA1509_29432, RNA1509_40562, RNA1509_47163, RNA1509_5612}
6. MligTC454_41867 Mlig112907.g1 8.04 Gamma neoblasts; Xins ACTG1 Mlig112907.g1 {REF} {Length: 1562} {Pfam: Actin [PF00022.19, score=418.8]} {Human: ENSG00000184009, ACTG1, actin gamma 1, [Score=622, Expect=0.0]; ENSG00000075624, ACTB, actin beta, [Score=621, Expect=0.0]; ENSG00000159251, ACTC1, actin, alpha, cardiac muscle 1, [Score=604, Expect=0.0]; ENSG00000107796, ACTA2, actin, alpha 2, smooth muscle, aorta, [Score=603, Expect=0.0]; ENSG00000163017, ACTG2, actin, gamma 2, smooth muscle, enteric, [Score=603, Expect=0.0]; ENSG00000169067, ACTBL2, actin, beta like 2, [Score=598, Expect=0.0]; ENSG00000143632, ACTA1, actin, alpha 1, skeletal muscle, [Score=598, Expect=0.0]} {Mouse: ENSMUSG00000062825, Actg1, actin, gamma, cytoplasmic 1, [Score=622, Expect=0.0]; ENSMUSG00000029580, Actb, actin, beta, [Score=621, Expect=0.0]; ENSMUSG00000068614, Actc1, actin, alpha, cardiac muscle 1, [Score=604, Expect=0.0]; ENSMUSG00000035783, Acta2, actin, alpha 2, smooth muscle, aorta, [Score=603, Expect=0.0]; ENSMUSG00000059430, Actg2, actin, gamma 2, smooth muscle, enteric, [Score=603, Expect=0.0]; ENSMUSG00000055194, Actbl2, actin, beta-like 2, [Score=600, Expect=0.0]; ENSMUSG00000031972, Acta1, actin, alpha 1, skeletal muscle, [Score=598, Expect=0.0]} {Dmel: FBgn0000043, Act42A, Actin 42A, [Score=625, Expect=0.0]} {Celegans: WBGene00000067, act-5, ACTin, [Score=604, Expect=0.0]} {Smed: dd_Smed_v6_3_0_1, dd_Smed_v6_3_0_1, [Score=626, Expect=0.0]} {RNA1509_13476, RNA1509_17616, RNA1509_51084} {SMEDTYPE: Gamma neoblasts [dd_Smed_v6_3_0_1, actin, beta (ACTB)]} {SMEDTYPE: Xins [raj_facs_types]}
7. MligTC454_41634 Mlig017064.g5 7.91 MOXD1 Mlig017064.g5 {REF} {Length: 2254} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.20, score=92.3]; Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.15, score=70.6]} {Human: ENSG00000079931, MOXD1, monooxygenase DBH like 1, [Score=120, Expect=5e-28]; ENSG00000123454, DBH, dopamine beta-hydroxylase, [Score=117, Expect=7e-27]} {Mouse: ENSMUSG00000020000, Moxd1, monooxygenase, DBH-like 1, [Score=135, Expect=5e-33]} {Dmel: FBgn0010329, Tbh, Tyramine beta hydroxylase, [Score=127, Expect=1e-30]} {Celegans: WBGene00006541, tbh-1, Tyramine beta-hydroxylase, [Score=139, Expect=7e-35]} {Smed: dd_Smed_v6_42610_0_1, dd_Smed_v6_42610_0_1, [Score=118, Expect=8e-29]} {RNA1509_127}
8. MligTC454_71232 Mlig007282.g2 7.91 AHCY Mlig007282.g2 {REF} {Length: 2029} {Pfam: S-adenosyl-L-homocysteine hydrolase [PF05221.17, score=452.5]; S-adenosyl-L-homocysteine hydrolase, NAD binding domain [PF00670.21, score=268.4]; D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain [PF02826.19, score=34.5]; Acetohydroxy acid isomeroreductase, NADPH-binding domain [PF07991.12, score=26.1]; Putative NAD(P)-binding [PF13241.6, score=19.9]} {Human: ENSG00000101444, AHCY, adenosylhomocysteinase, [RH, Score=683, Expect=0.0]} {Mouse: ENSMUSG00000048087, Gm4737, predicted gene 4737, [RH, Score=676, Expect=0.0]; ENSMUSG00000027597, Ahcy, S-adenosylhomocysteine hydrolase, [RH, Score=676, Expect=0.0]} {Dmel: FBgn0014455, Ahcy, Adenosylhomocysteinase, [RH, Score=717, Expect=0.0]} {Celegans: WBGene00019322, ahcy-1, Adenosylhomocysteinase, [RH, Score=723, Expect=0.0]} {Smed: dd_Smed_v6_526_0_1, dd_Smed_v6_526_0_1, [RH, Score=743, Expect=0.0]} {RNA1509_1422, RNA1509_1799, RNA1509_255}
9. MligTC454_58026 Mlig007627.g6 7.73 Xins PCK2 Mlig007627.g6 {REF} {Length: 2751} {TRANSSPLICED} {Pfam: Phosphoenolpyruvate carboxykinase C-terminal P-loop domain [PF00821.18, score=530.2]; Phosphoenolpyruvate carboxykinase N-terminal domain [PF17297.2, score=308.2]} {Human: ENSG00000285241, PCK2, phosphoenolpyruvate carboxykinase 2, mitochondrial, [Score=766, Expect=0.0]; ENSG00000100889, PCK2, phosphoenolpyruvate carboxykinase 2, mitochondrial, [Score=766, Expect=0.0]; ENSG00000124253, PCK1, phosphoenolpyruvate carboxykinase 1, [Score=749, Expect=0.0]} {Mouse: ENSMUSG00000040618, Pck2, phosphoenolpyruvate carboxykinase 2 (mitochondrial), [Score=780, Expect=0.0]; ENSMUSG00000027513, Pck1, phosphoenolpyruvate carboxykinase 1, cytosolic, [Score=762, Expect=0.0]} {Dmel: FBgn0034356, CG10924, [Score=720, Expect=0.0]} {Celegans: WBGene00011232, pck-2, Phosphoenolypyruvate CarboxyKinase, [RH, Score=879, Expect=0.0]} {Smed: dd_Smed_v6_196_0_1, dd_Smed_v6_196_0_1, [RH, Score=935, Expect=0.0]} {RNA1509_1014, RNA1509_1514, RNA1509_28100, RNA1509_31592, RNA1509_45611, RNA1509_488, RNA1509_57691} {SMEDTYPE: Xins [raj_facs_types]}
10. MligTC454_31195 Mlig018526.g1 7.61 Muscle; Xins; Asexual_biased Mlig018526.g1 {REF} {Length: 4478} {Pfam: PLAC8 family [PF04749.17, score=79.0]} {Smed: dd_Smed_v6_477_0_1, dd_Smed_v6_477_0_1, [RH, Score=129, Expect=2e-40]} {RNA1509_10477, RNA1509_10789, RNA1509_11416, RNA1509_13483, RNA1509_13946, RNA1509_14839, RNA1509_16689, RNA1509_1735, RNA1509_21370, RNA1509_24499, RNA1509_29492, RNA1509_41089, RNA1509_7129} {SMEDTYPE: Muscle [dd_Smed_v6_477_0_1, placenta-specific 8 (PLAC8)]} {SMEDTYPE: Xins [raj_facs_types]} {SMEDTYPE: Asexual_biased [CUFF.521209.0]}
11. MligTC454_58405 Mlig022175.g4 7.59

 Int S/G2/M 

DYNLL2 Mlig022175.g4 {REF} {Length: 980} {TRANSSPLICED} {Pfam: Dynein light chain type 1 [PF01221.18, score=148.1]} {Human: ENSG00000264364, DYNLL2, dynein light chain LC8-type 2, [RH, Score=184, Expect=3e-62]; ENSG00000088986, DYNLL1, dynein light chain LC8-type 1, [RH, Score=180, Expect=2e-60]} {Mouse: ENSMUSG00000020483, Dynll2, dynein light chain LC8-type 2, [RH, Score=184, Expect=2e-62]; ENSMUSG00000009013, Dynll1, dynein light chain LC8-type 1, [RH, Score=180, Expect=1e-60]} {Dmel: FBgn0011760, ctp, cut up, [RH, Score=183, Expect=4e-62]} {Celegans: WBGene00001005, dlc-1, Dynein light chain 1, cytoplasmic, [RH, Score=179, Expect=1e-60]} {Smed: dd_Smed_v6_310_0_1, dd_Smed_v6_310_0_1, [RH, Score=179, Expect=1e-60]} {RNA1509_14361, RNA1509_1502, RNA1509_22168, RNA1509_40636, RNA1509_44268, RNA1509_8211, RNA1509_929}
12. MligTC454_67438 Mlig025790.g24 7.56 Testis; Sexual_biased CKB Mlig025790.g24 {REF} {Length: 5753} {Pfam: ATP:guanido phosphotransferase, C-terminal catalytic domain [PF00217.19, score=1070.7]; ATP:guanido phosphotransferase, N-terminal domain [PF02807.15, score=389.1]; flt3 ligand [PF02947.14, score=36.9]; Domain of unknown function (DUF4581) [PF15167.6, score=25.5]; Sir4 SID domain [PF16991.5, score=24.8]; Small, acid-soluble spore protein I [PF14098.6, score=24.0]; Latarcin precursor [PF10279.9, score=23.5]; SF-assemblin/beta giardin [PF06705.11, score=22.4]; Ribonuclease toxin, BrnT, of type II toxin-antitoxin system [PF04365.13, score=21.3]; Plectin repeat [PF00681.20, score=19.7]; Polyhydroxyalkanoic acid inclusion protein (PhaP_Bmeg) [PF09602.10, score=19.0]} {Human: ENSG00000166165, CKB, creatine kinase B, [RH, Score=296, Expect=3e-89]} {Mouse: ENSMUSG00000001270, Ckb, creatine kinase, brain, [RH, Score=292, Expect=6e-88]; ENSMUSG00000030399, Ckm, creatine kinase, muscle, [RH, Score=286, Expect=9e-86]} {Dmel: FBgn0000116, Argk, Arginine kinase, [RH, Score=550, Expect=1e-180]} {Celegans: WBGene00018519, F46H5.3, Probable arginine kinase F46H5.3, [RH, Score=473, Expect=7e-154]} {Smed: dd_Smed_v6_67158_0_1, dd_Smed_v6_67158_0_1, [RH, Score=252, Expect=7e-76]} {RNA1509_1711} {SMEDTYPE: Testis [Contig5990_SE3]} {SMEDTYPE: Sexual_biased [CUFF.514182.0]}
13. MligTC454_74208 Mlig101393.g2 7.4 Testis; Sexual_biased CKB Mlig101393.g2 {REF} {Length: 7554} {Pfam: ATP:guanido phosphotransferase, C-terminal catalytic domain [PF00217.19, score=1603.5]; ATP:guanido phosphotransferase, N-terminal domain [PF02807.15, score=596.2]; flt3 ligand [PF02947.14, score=55.4]; Small, acid-soluble spore protein I [PF14098.6, score=40.0]; Arc C-lobe [PF18162.1, score=36.1]; Centromere kinetochore component CENP-T histone fold [PF15511.6, score=32.6]; Terminase small subunit [PF03592.16, score=31.8]; Ribonuclease toxin, BrnT, of type II toxin-antitoxin system [PF04365.13, score=30.4]; WD40 associated region in TFIID subunit, NTD2 domain [PF04494.15, score=29.8]; Plectin repeat [PF00681.20, score=26.3]; Latarcin precursor [PF10279.9, score=25.0]; Phage late-transcription coactivator [PF16805.5, score=23.4]; Vacuolar sorting protein 9 (VPS9) domain [PF02204.18, score=21.1]} {Human: ENSG00000166165, CKB, creatine kinase B, [RH, Score=295, Expect=2e-88]} {Mouse: ENSMUSG00000001270, Ckb, creatine kinase, brain, [RH, Score=292, Expect=1e-87]; ENSMUSG00000030399, Ckm, creatine kinase, muscle, [RH, Score=287, Expect=7e-86]} {Dmel: FBgn0000116, Argk, Arginine kinase, [RH, Score=531, Expect=3e-169]} {Celegans: WBGene00018519, F46H5.3, Probable arginine kinase F46H5.3, [RH, Score=448, Expect=1e-142]} {Smed: dd_Smed_v6_67158_0_1, dd_Smed_v6_67158_0_1, [RH, Score=254, Expect=3e-76]} {RNA1509_1711} {SMEDTYPE: Testis [Contig5990_SE3]} {SMEDTYPE: Sexual_biased [CUFF.514182.0]}
14. MligTC454_42875 Mlig032113.g1 7.34

 Int S/G2/M 

X1; Xins; self-renewal TUBB3 Mlig032113.g1 {REF} {Length: 2431} {TRANSSPLICED} {Pfam: Tubulin/FtsZ family, GTPase domain [PF00091.25, score=236.3]; Tubulin C-terminal domain [PF03953.17, score=148.5]; Misato Segment II tubulin-like domain [PF10644.9, score=23.8]} {Human: ENSG00000258947, TUBB3, tubulin beta 3 class III, [RH, Score=836, Expect=0.0]; ENSG00000176014, TUBB6, tubulin beta 6 class V, [RH, Score=813, Expect=0.0]} {Mouse: ENSMUSG00000062380, Tubb3, tubulin, beta 3 class III, [RH, Score=835, Expect=0.0]} {Dmel: FBgn0003889, betaTub85D, beta-Tubulin at 85D, [RH, Score=839, Expect=0.0]} {Celegans: WBGene00006538, tbb-4, Tubulin beta-4 chain, [RH, Score=852, Expect=0.0]} {Smed: dd_Smed_v6_83_0_1, dd_Smed_v6_83_0_1, [Score=860, Expect=0.0]} {RNA1509_14740, RNA1509_16057, RNA1509_24183, RNA1509_32382, RNA1509_33143, RNA1509_42980, RNA1509_53009, RNA1509_56081, RNA1509_900, RNA1509_9944} {SMEDTYPE: X1; Xins [raj_facs_types]} {SMEDTYPE: self-renewal [4]}
15. MligTC454_74675 Mlig005648.g3 7.28 PKD2 Mlig005648.g3 {REF} {Length: 3123} {TRANSSPLICED} {Pfam: Polycystin cation channel [PF08016.12, score=472.5]; Ion transport protein [PF00520.31, score=89.3]; Ferredoxin I 4Fe-4S cluster domain [PF18109.1, score=35.3]; EF hand [PF00036.32, score=29.2]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [Score=733, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=733, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=310, Expect=8e-92]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=363, Expect=4e-114]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=744, Expect=0.0]} {RNA1509_54167}
16. MligTC454_69969 Mlig024387.g3 7.16

 Irradiation 

 Int S/G2/M 

Neoblast; X1 Mlig024387.g3 {REF} {Length: 1524} {Pfam: linker histone H1 and H5 family [PF00538.19, score=96.0]} {Mouse: ENSMUSG00000096210, H1f0, H1 histone family, member 0, [RH, Score=92.4, Expect=8e-23]} {Dmel: FBgn0053825, His1:CG33825, [Score=64.7, Expect=3e-12]} {Celegans: WBGene00001856, hil-5, Histone H1.5, [RH, Score=79.3, Expect=8e-18]} {Smed: dd_Smed_v6_601_0_1, dd_Smed_v6_601_0_1, [Score=53.5, Expect=1e-08]} {RNA1509_14181, RNA1509_17023, RNA1509_18379, RNA1509_18394, RNA1509_26253, RNA1509_28785, RNA1509_44806, RNA1509_48932, RNA1509_8272, RNA1509_8822} {SMEDTYPE: Neoblast [dd_Smed_v6_601_0_1, clone PL04013A1A11 histone H1]} {SMEDTYPE: X1 [raj_facs_types]}
17. MligTC454_71707 Mlig033649.g1 7.09 Mlig033649.g1 {REF} {Length: 1340} {RNA1509_3560, RNA1509_36840, RNA1509_42552, RNA1509_4845, RNA1509_7701}
18. MligTC454_39265 Mlig026306.g3 6.94 Mlig026306.g3 {REF} {Length: 2074} {RNA1509_11780, RNA1509_18409}
19. MligTC454_42876 Mlig025671.g9 6.89 X1; Xins; self-renewal TUBB3 Mlig025671.g9 {REF} {Length: 2459} {TRANSSPLICED} {Pfam: Tubulin/FtsZ family, GTPase domain [PF00091.25, score=236.3]; Tubulin C-terminal domain [PF03953.17, score=148.5]; Misato Segment II tubulin-like domain [PF10644.9, score=23.8]} {Human: ENSG00000258947, TUBB3, tubulin beta 3 class III, [RH, Score=836, Expect=0.0]; ENSG00000176014, TUBB6, tubulin beta 6 class V, [RH, Score=813, Expect=0.0]} {Mouse: ENSMUSG00000062380, Tubb3, tubulin, beta 3 class III, [RH, Score=835, Expect=0.0]} {Dmel: FBgn0003889, betaTub85D, beta-Tubulin at 85D, [RH, Score=839, Expect=0.0]} {Celegans: WBGene00006538, tbb-4, Tubulin beta-4 chain, [RH, Score=852, Expect=0.0]} {Smed: dd_Smed_v6_83_0_1, dd_Smed_v6_83_0_1, [Score=860, Expect=0.0]} {RNA1509_19640, RNA1509_19789, RNA1509_25795, RNA1509_27047, RNA1509_44994, RNA1509_900} {SMEDTYPE: X1; Xins [raj_facs_types]} {SMEDTYPE: self-renewal [4]}
20. MligTC454_62432 Mlig036118.g15 6.75 Xins; Asexual_biased PC Mlig036118.g15 {REF} {Length: 5358} {TRANSSPLICED} {Pfam: Carbamoyl-phosphate synthase L chain, ATP binding domain [PF02786.17, score=265.4]; Biotin carboxylase, N-terminal domain [PF00289.22, score=117.3]; Biotin carboxylase C-terminal domain [PF02785.19, score=104.9]; ATP-grasp domain [PF02222.22, score=36.5]; D-ala D-ala ligase C-terminus [PF07478.13, score=33.9]; ATP-grasp domain [PF02655.14, score=18.8]} {Human: ENSG00000173599, PC, pyruvate carboxylase, [Score=837, Expect=0.0]} {Mouse: ENSMUSG00000024892, Pcx, pyruvate carboxylase, [Score=826, Expect=0.0]} {Dmel: FBgn0027580, PCB, Pyruvate carboxylase, [Score=839, Expect=0.0]} {Celegans: WBGene00004258, pyc-1, Pyruvate carboxylase 1, [Score=808, Expect=0.0]} {Smed: dd_Smed_v6_2393_0_1, dd_Smed_v6_2393_0_1, [Score=851, Expect=0.0]} {RNA1509_24998, RNA1509_292} {SMEDTYPE: Xins [raj_facs_types]} {SMEDTYPE: Asexual_biased [CUFF.488931.0]}
First Previous 1 2 3 Next Last
Berezikov Lab - 2016-2021 © ERIBA